Jason C. Jones - Nov 5, 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Chief Operating Officer
Signature: /s/ Jerome Wong
Stock symbol: EKSO
Transactions as of: Nov 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 11/7/2025, 05:48 PM
Previous filing: Mar 18, 2025
Next filing: Nov 12, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jones Jason C	Chief Operating Officer	101 GLACIER POINT, SUITE A, SAN RAFAEL	/s/ Jerome Wong	2025-11-07	0001775619

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Award	$0	+15K	+68.39%	$0.00	36.9K	Nov 5, 2025	Direct	F1, F2, F3
holding	EKSO	Common Stock						3.14K	Nov 5, 2025	By 401(k)	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2	The RSU grant was approved by the Board of Directors in a meeting held on November 5, 2025, under the Company's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). Each RSU Award was fully vested at grant.
F3	On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.